European Equities – Diversifying US Dominance
Roundtable Highlights Reels
the Virtual Panel assembled a group of leading investors in European Equities in April 2025. The debate was detailed, fascinating and included an array of topics with three elite portfolio managers with differentiated styles.
In these short highlight reel interviews with the portfolio managers, we focus on the key areas of debate:
- Why Europe is positioned favourably on valuation and earnings growth relative to the US and its own history
- The outlook for value, quality and small/mid cap
- Why European reform could trigger a recovery in performance and capital flow
- Sector opportunities and outlook across healthcare, banks, insurers and consumer staples
With big thanks to our panellists:
Sophie Outhwaite of Quilter Investors,
David Morcher of Avellemy,
Anais Gfeller of Lombard Odier,
Billy Ewins of Quilter Cheviot, and
Catherine Sathi of Columbia Threadneedle.
Artemis’ Philip Wolstencroft sets out:
- Why the cards are stacked in Europe’s favour relative to the US on valuation and relative earnings growth,
- Why European Value has room to run despite strong recent performance
- Why Banks and Insurers are screening well in Artemis’ SmartGARP process
Carmignac’s Mark Denham explores:
- Why Quality Growth in Europe? Why it has under-performed in 2025, and why this presents a buying opportunity,
- The rich range of opportunity in European healthcare names,
- Where Denham is seeing value in other sectors in Europe
Goodhart Partners’ James Sym covers:
- Why Trump’s MAGA approach and tariff regime could further stimulate European reform and deliver performance,
- Why Small and Mid cap names offer great potential on valuation grounds,
- Insight into Sym’s business cycle investment approach